Page last updated: 2024-12-05
trifenmorph
Description
Trifenmorph, also known as tridemorph, is a fungicide used to control powdery mildew in various crops. It is synthesized through a series of reactions involving chlorination, alkylation, and condensation. Trifenmorph inhibits the biosynthesis of ergosterol, a crucial component of fungal cell membranes, leading to disruption of cell growth and development. It exhibits both preventive and curative action against powdery mildew. Due to its effectiveness and relatively low toxicity to mammals, trifenmorph is widely used in agriculture. However, concerns regarding its potential environmental impact and the emergence of resistant fungal strains have led to ongoing research on its mode of action, alternative fungicides, and sustainable practices.'
trifenmorph: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 14993 |
CHEMBL ID | 2086832 |
CHEBI ID | 82264 |
SCHEMBL ID | 435727 |
MeSH ID | M0042375 |
Synonyms (36)
Synonym |
unii-h1il51k9cw |
h1il51k9cw , |
trifenmorph [iso:bsi] |
caswell no. 898a |
wl 8008 |
einecs 215-812-2 |
triphenmorphe |
ai3-51843 |
morpholine, n-trityl- |
n-tritylmorpholine |
frescon |
n-(triphenyl-methyl)morpholine |
epa pesticide chemical code 498300 |
morpholine, 4-(triphenylmethyl)- |
morpholine, 4-trityl- |
trifenmorph |
4-tritylmorpholine |
hsdb 1785 |
shell wl 8008 |
brn 1223254 |
4-(triphenylmethyl)morpholine |
NCGC00160549-01 |
AKOS003382578 |
C19144 |
1420-06-0 |
chebi:82264 , |
CHEMBL2086832 |
trifenmorph [hsdb] |
trifenmorph [mart.] |
trifenmorph [mi] |
trifenmorph [iso] |
SCHEMBL435727 |
n-(triphenylmethyl)morpholine |
DTXSID6042492 |
4-tritylmorpholine # |
Q27155848 |
Research Excerpts
Toxicity
Drug Classes (1)
Class | Description |
morpholines | Any compound containing morpholine as part of its structure. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 12 (85.71) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 16.52
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 16.52 (24.57) | Research Supply Index | 2.77 (2.92) | Research Growth Index | 4.12 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (13.33%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (86.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |